MedTrace Logo

A Genomic Analysis of Evolution of Epithelia Ovarian Tumors

NCT03742388 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2018-11-15

No results posted yet for this study

Summary

Epithelial ovarian carcinomatous and borderline components sometimes appeared in one patient. This study aims to analyze the genomic patterns of the carcinomatous and borderline components in the ovarian epithelial tissues. These tissues will be collected from paraffin section by microdissection to distinguish normal, carcinomatous and borderline tissues.

Conditions

  • Epithelial Ovarian Cancer
  • Epithelial Ovarian Tumor of Borderline Malignancy
  • Driving Mutations
  • Progression-free Survival

Sponsors & Collaborators

  • Lei Li

    lead OTHER

Principal Investigators

  • Lei Li, M.D. · Peking Union Medical College Hospital

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-10
Primary Completion
2020-12-23
Completion
2020-12-23

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03742388 on ClinicalTrials.gov